When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Acceleron Pharma (NASDAQ:XLRN) is scheduled to announce Q3 earnings results on Thursday, November 5th, after market close.The consensus EPS Estimate is -$0.56 (+34.9% Y/Y) and the consensus Revenue Estimate is $26.52M (+529.9% Y/Y).Over the last 2 years, XLRN has beaten EPS estimates 50% of the time and has beaten revenue estimates 25% of the time.Over the last 3 months, EPS estimates have seen 3 upward revisions and 6 downward. Revenue estimates have seen 7 upward revisions and 1 downward.